Celularity Inc. (CELU) Financial Statements

Income statement

Metric	TTM	2025	2024	2023	2022
Revenue
Total Revenue	26.6M	26.6M	54.2M	22.8M	18.0M
Cost of Revenue	6.4M	6.4M	15.0M	16.0M	19.7M
Gross Profit	20.2M	20.2M	39.2M	6.8M	(1.7M)
Operating Expenses
R&D Expense	15.0M	15.0M	17.4M	30.5M	78.4M
SG&A Expense	51.3M	51.3M	58.6M	50.6M	66.0M
General & Admin Expense	—	—	58.6M	50.5M	65.9M
Selling & Marketing Expense	—	—	23.0K	44.0K	163.0K
Other Expenses	15.2M	15.2M	1.6M	118.0M	(120.5M)
Total Operating Expenses	81.5M	81.5M	77.6M	199.0M	23.9M
Cost and Expenses	87.9M	87.9M	92.6M	215.1M	43.6M
Operating Income (EBIT)	(61.3M)	(61.3M)	(38.4M)	(192.3M)	(25.6M)
Non-Operating
Interest Income	262.0K	262.0K	331.0K	320.0K	365.0K
Interest Expense	6.8M	6.8M	6.3M	3.0M	—
Net Interest Income	(6.5M)	(6.5M)	(5.9M)	(2.7M)	365.0K
Other Non-Op Income/Expense	(30.4M)	(30.4M)	(19.5M)	(4.0M)	39.8M
Non-Operating Income (excl Interest)	23.7M	23.7M	13.3M	983.0K	122.7M
EBT (Pre-Tax Income)	(91.7M)	(91.7M)	(57.9M)	(196.3M)	14.2M
Income Tax Expense	—	3.0K	—	10.0K	13.0K
Bottom Line
Net Income	(91.7M)	(91.8M)	(57.9M)	(196.3M)	14.2M
Earnings from Cont. Ops	(91.7M)	(91.7M)	(57.9M)	(196.3M)	14.2M
Earnings from Discont. Ops	—	—	—	—	—
Bottom Line Net Income	(91.8M)	(91.8M)	(57.9M)	(196.3M)	14.2M
Per Share
Basic EPS	($3.69)	($3.59)	($2.64)	($11.02)	$1.01
Diluted EPS	($3.69)	($3.59)	($2.64)	($11.02)	$0.95
Revenue Per Share	$1.04	$1.04	$2.48	$1.28	$1.28
Shares
Basic Shares Outstanding	25.6M	25.6M	21.9M	17.8M	14.0M
Diluted Shares Outstanding	25.6M	25.6M	21.9M	17.8M	15.0M
Profitability Metrics
EBITDA	(77.6M)	(77.7M)	(43.7M)	(183.9M)	(138.8M)
D&A	7.3M	7.3M	7.9M	9.3M	9.4M
EBIT	(85.0M)	(85.0M)	(51.6M)	(193.3M)	(148.3M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Dec 1, 2025